ArticlePharmacoepidemiology and drug safety2020

Impact of EMA regulatory label changes on systemic diclofenac initiation, discontinuation, and switching to other pain medicines in Scotland, England, Denmark, and The Netherlands.

Daniel R Morales et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.